Navigation Links
ThermoGenesis Corp. Provides Updated Information for Conference Call/Webcast to Discuss Management Transition
Date:12/3/2008

new products scheduled for fiscal year 2009, and introduction of competitive products and other factors beyond our control, could result in a materially different revenue outcome and/or in our failure to achieve the revenue levels we expect for fiscal 2009. A more complete description of these and other risks that could cause actual events to differ from the outcomes predicted by our forward-looking statements is set forth under the caption "Risk Factors" in our annual report on Form 10-K and other reports we file with the Securities and Exchange Commission from time to time, and you should consider each of those factors when evaluating the forward-looking statements.

     ThermoGenesis Corp.
     Web site:http://www.thermogenesis.com
     Contact: Investor Relations
     +1-916-858-5107, or
     ir@thermogenesis.com

'/>"/>
SOURCE ThermoGenesis Corp.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. ThermoGenesis Announces 510(k) Clearance for AutoXpress(TM) Cord Blood Processing System
2. ThermoGenesis Corp. Reports First Quarter 2008 Results
3. Thermogenesis Announces New Initiative to Address Veterinary Regenerative Medicine
4. ThermoGenesis Announces Filing of 510(k) Application for MarrowXpress
5. ThermoGenesis Announces 10 New BioArchive(R) System Distributors
6. ThermoGenesis Reports First Quarter 2009 Results
7. ThermoGenesis Announces Management Transition; Provides Update on Operational Milestones
8. ThermoGenesis Corp. Schedules Conference Call/Webcast to Discuss Management Transition
9. Paramount Acquisition Corp. Announces Chem Rx Expansion into Albany, New York Market
10. MaxLife Fund Corp. purchases a portfolio of Life Settlement Policies with a face value of $4,000,000
11. Authentidate Holding Corp. to Report Fourth Quarter and Fiscal 2007 Year End Results on Thursday, September 13, 2007
Post Your Comments:
*Name:
*Comment:
*Email: